فرآورده‌های‌ تزریقی‌ ایران‌

دفرا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

-

Last Price: - 0.00
Close Price: -

Cash Flow

2026/06/11
Fiscal Year 2026/03/2012 Month / Audited
2026/06/10
Fiscal Year 2026/03/2012 Month

Cash Generated from Operations

11.496 Trillion11.284 Trillion

Income Taxes Paid

-1.604 Trillion-1.604 Trillion

Net Cash Flow from Operating Activities

9.892 Trillion9.68 Trillion

Proceeds from Sale of Property, Plant and Equipment

292 Million292 Million

Purchases of Property, Plant and Equipment

-535.482 Billion-535.482 Billion

Purchases of Intangible Assets

-8.65 Billion-8.65 Billion

Proceeds from Sale of Long-Term Investments

2.48 Trillion2.48 Trillion

Cash Paid to Acquire Long-Term Investments

-7.43 Trillion-7.43 Trillion

Cash Paid to Acquire Short-Term Investments

-620 Billion-620 Billion

Cash Received from Income on Other Investments

822.504 Billion821.959 Billion

Net Cash Flow from Investing Activities

-5.291 Trillion-5.117 Trillion

Net Cash Flow before Financing Activities

4.601 Trillion4.563 Trillion

Cash Received from Capital Increases of Subsidiaries

-829 Million

Proceeds from Sale of Treasury Shares

5.28 Billion5.28 Billion

Purchases of Treasury Shares

-48.279 Billion-48.278 Billion

Cash Received from Borrowings

3.739 Trillion3.739 Trillion

Repayments of Borrowings (Principal)

-3.47 Trillion-3.47 Trillion

Interest Paid on Borrowings

-181.895 Billion-181.895 Billion

Dividends Paid

-3.792 Trillion-3.792 Trillion

Other Cash Flows from Financing Activities

829 Million-

Net Cash Flow from Financing Activities

-3.747 Trillion-3.835 Trillion

Net Increase (Decrease) in Cash

853.929 Billion727.892 Billion

Cash at Beginning of Period

1.102 Trillion1.102 Trillion

Effect of Exchange Rate Changes

818 Million818 Million

Cash at End of Period

1.102 Trillion721.548 Billion

Non-Cash Transactions

350 Billion3.199 Trillion